Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

79
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
79
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

110
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
110
Data Validation01:15

Data Validation

3.3K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
3.3K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

253
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
253
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

1.3K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.3K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

935
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
935

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective evaluation of the OECD adopted in vitro skin irritation/corrosion tests for agrochemical formulations.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction.

Journal of visualized experiments : JoVE·2026
Same author

Stakeholder input towards further refinement and consolidation of the alternative safety profiling algorithm (ASPA) for next generation risk assessment (NGRA).

ALTEX·2026
Same author

A quantitative definition for poorly soluble particles.

Particle and fibre toxicology·2026
Same author

Inclusion of a recovery period after pulse treatment in the primary human lymphocyte micronucleus assay covers potential cell cycle delays without loss of sensitivity.

Mutagenesis·2026
Same author

Combined assessment of transgenic rodent gene mutation and micronuclei formation by benzo[a]pyrene, N-ethyl-N-nitrosourea, 2,4-diaminotoluene and ethyl carbamate.

Mutation research. Genetic toxicology and environmental mutagenesis·2026

Related Experiment Video

Updated: Mar 7, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

896

The borderline range of toxicological methods: Quantification and implications for evaluating precision.

Maria Leontaridou1,2, Daniel Urbisch2, Susanne N Kolle2

  • 1Wageningen University, Environmental Economics and Natural Resources Group, Wageningen, the Netherlands.

ALTEX
|February 24, 2017
PubMed
Summary
This summary is machine-generated.

Identifying a borderline range in skin sensitization testing is crucial. This range highlights inconclusive results due to biological and technical variability, impacting regulatory hazard assessment.

Keywords:
borderline rangenon-animal methodsvariabilityskin sensitisation

More Related Videos

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.8K
Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

9.2K

Related Experiment Videos

Last Updated: Mar 7, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

896
Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
08:33

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

11.8K
Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

9.2K

Area of Science:

  • Toxicology
  • Dermatology
  • Regulatory Science

Background:

  • Standard toxicological assessments use threshold criteria for dichotomous classification of substance properties.
  • Regulatory hazard assessment relies on these classifications for labeling and safety evaluations.
  • Variability in test methods can lead to inconclusive results around classification thresholds.

Purpose of the Study:

  • To quantify the borderline range (BR) in non-animal (DPRA, LuSens, h-CLAT) and animal (LLNA) test methods for skin sensitization.
  • To assess the impact of borderline results on integrated testing strategies (ITS).
  • To propose an enhanced classification system that includes an 'inconclusive' category.

Main Methods:

  • Quantification of borderline ranges (BRs) for DPRA, LuSens, h-CLAT, and LLNA.
  • Analysis of borderline results in a 2-out-of-3 integrated testing strategy (ITS).
  • Evaluation of the proportion of substances falling within the BR for individual methods and ITS.

Main Results:

  • Between 6% and 28% of tested substances fell within the BR for individual non-animal and animal methods.
  • In a 2-out-of-3 ITS, 10% of substances (4 out of 40) yielded borderline results.
  • Borderline results from individual tests influenced the overall assessment in integrated strategies.

Conclusions:

  • A significant proportion of substances yield borderline results in skin sensitization testing due to inherent variability.
  • Current binary classification (positive/negative) may not adequately represent substances with inconclusive test outcomes.
  • Expanding classification to include a 'borderline' or 'inconclusive' alert is proposed to improve regulatory assessment accuracy.